Provided by Tiger Fintech (Singapore) Pte. Ltd.

Celldex Therapeutics

22.89
-0.0200-0.09%
Volume:36.52K
Turnover:836.41K
Market Cap:1.52B
PE:-8.48
High:23.16
Open:22.79
Low:22.64
Close:22.91
Loading ...
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 04, 2021

Major Issues Report

8-K - Current report
Nov 06, 2020

Major Issues Report

8-K - Current report
Nov 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2020

Major Issues Report

8-K - Current report
Oct 22, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 18, 2020

Major Issues Report

8-K - Current report
Aug 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2020

Major Issues Report

8-K - Current report
Jul 24, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 26, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 26, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jun 19, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 18, 2020

Major Issues Report

8-K - Current report
Jun 18, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 17, 2020

Major Issues Report

8-K - Current report
Jun 15, 2020

Major Issues Report

8-K - Current report
Jun 12, 2020

Correspondence

CORRESP [Cover] - Correspondence